Simple Summary Numerous mechanisms of glioblastoma (GBM) radioresistance have been
identified but have not yet resulted in development of effective radiosensitizer that can …

Both apoptosis and autophagy are highly conserved processes that besides their role in the
maintenance of the organismal and cellular homeostasis serve as a main target of tumor …

Malignant glioma is a severe type of brain tumor with a poor prognosis and few options for
therapy. The main chemotherapy protocol for this type of tumor is based on temozolomide …

Melittin (MLT) treatment is believed to enhance tumor cell death, apoptotic, and oxidative
cytotoxic effects of cisplatin (CSP) via the modulation of Ca 2+ channels in several cancer …

Purpose Glioblastoma (GBM) is the commonest brain tumour in adults. A sub-population of
cells within these tumours, known as cancer stem cells (CSCs), is thought to mediate their …

Glioblastoma (GBM) cells express large‐conductance, calcium‐activated potassium (BK)
channels, whose activity is important for several critical aspects of the tumor, such as …

There is an urgent need to develop nanocarriers for the treatment of glioblastoma multiforme
(GBM). Using co-registered positron emission tomography (PET) and magnetic resonance …

Glioblastoma (GBM), a high-grade glioma (WHO grade IV), is the most aggressive form of
brain cancer. Available treatment options for GBM involve a combination of surgery …

Glioblastoma multiforme is a highly aggressive brain tumor whose prognosis is very poor.
Due to early invasion of brain parenchyma, its complete surgical removal is nearly …

Background Glioblastoma is the most common type of primary brain tumors. Cisplatin is a
commonly used chemotherapeutic agent for Glioblastoma patients. Despite a consistent rate …